Ststent Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 2


  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 3

Ststent General Information


Developer of a nasal stent device designed to treat chronic sinusitis and promote better healing without drugs. The company device offers precise positioning and prevents middle turbinate lateralization, enabling patients to have improved outcomes and reduced probability of revision surgeries.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Corporate Office
  • Misgav Business Park
  • 17 Tchelet Street
  • Misgav 2017400
  • Israel
+972 000-000-0000

Ststent Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ststent Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 01-Jul-2024 00.000 Completed Generating Revenue
5. Equity Crowdfunding 01-Nov-2022 00.000 00.000 Completed Generating Revenue
4. Grant 20-Jun-2018 000.00 00000 Completed Generating Revenue
3. Early Stage VC 28-Apr-2015 00000 00000 Completed Generating Revenue
2. Early Stage VC 01-Nov-2013 $100K $100K Completed Startup
1. Grant 01-Nov-2013 $706K Completed Startup
To view Ststent’s complete valuation and funding history, request access »

Ststent Comparisons

HQ Location
Total Raised
Post Valuation
Developer of a nasal stent device designed to treat chronic sinusitis and promote better healing without drugs. The comp
Therapeutic Devices
Misgav, Israel
2 As of 2024
0000000000 0 00.000


re magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco labo
00000000000 0000000
Braintree, MA
00 As of 0000
0000000000 0 000.00


iam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo con
00000000000 0000000
Menlo Park, CA
000 As of 0000
00.00 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ststent Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Neurent Medical Venture Capital-Backed Braintree, MA 00 000.00 0000000000 0 000.00
Intersect ENT Formerly VC-backed Menlo Park, CA 000 00000 000000&0 00000
ENTvantage Dx Venture Capital-Backed Austin, TX 0 00.000 000000000000 00.000
Spine Wave Venture Capital-Backed Shelton, CT 000 00000 00000000000 00000
Altamira Therapeutics Formerly VC-backed Hamilton, Bermuda 00 00000 00000000 00000
You’re viewing 5 of 9 competitors. Get the full list »

Ststent Patents

Ststent Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10912663-B2 Shape change structure for treatment of nasal conditions including sinusitis Active 26-Nov-2014 00000000 00
US-20180360626-A1 Shape change structure for treatment of nasal conditions including sinusitis Active 26-Nov-2014 00000000 0
JP-2016519972-A Shape change structure Active 23-May-2013 000000000 0
JP-6488282-B2 Shape change structure Active 23-May-2013 000000000
US-10953141-B2 Shape change structure Active 23-May-2013 A61L31/022 00
To view Ststent’s complete patent history, request access »

Ststent Executive Team (1)

Name Title Board Seat Contact Info
Joseph Flomenblit Ph.D Founder & Chief Executive Officer
To view Ststent’s complete executive team members history, request access »

Ststent Board Members (2)

Name Representing Role Since
Michael Berman Self Chairman 000 0000
You’re viewing 1 of 2 board members. Get the full list »

Ststent Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ststent Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Katao Venture Partners Venture Capital Minority 000 0000 000000 0
Horizon 2020 SME Instrument Government 000 0000 000000 0
Trendlines Venture Capital Minority 000 0000 000000 0
To view Ststent’s complete investors history, request access »

Ststent FAQs

  • When was Ststent founded?

    Ststent was founded in 2013.

  • Who is the founder of Ststent?

    Joseph Flomenblit Ph.D is the founder of Ststent.

  • Who is the CEO of Ststent?

    Joseph Flomenblit Ph.D is the CEO of Ststent.

  • Where is Ststent headquartered?

    Ststent is headquartered in Misgav, Israel.

  • What is the size of Ststent?

    Ststent has 2 total employees.

  • What industry is Ststent in?

    Ststent’s primary industry is Therapeutic Devices.

  • Is Ststent a private or public company?

    Ststent is a Private company.

  • What is Ststent’s current revenue?

    The current revenue for Ststent is 00000.

  • How much funding has Ststent raised over time?

    Ststent has raised $1.81M.

  • Who are Ststent’s investors?

    Katao Venture Partners, Horizon 2020 SME Instrument, and Trendlines have invested in Ststent.

  • Who are Ststent’s competitors?

    Neurent Medical, Intersect ENT, ENTvantage Dx, Spine Wave, and Altamira Therapeutics are some of the 9 competitors of Ststent.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »